Financhill
Back

AbbVie 10K Form

Buy
60

ABBV
AbbVie

Last Price:
135.66
Seasonality Move:
8.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive ABBV News And Ratings

See the #1 stock for the next 7 days that we like better than ABBV

ABBV Financial Statistics

Sales & Book Value

Annual Sales: $56.2B
Cash Flow: $4.86B
Price / Cash Flow: 11.42
Annual Sales: $8.29
Price / Book: 17.22

Profitability

EPS (TTM): 7.06000
Net Income (TTM): $12.64B
Gross Margin: $38.75B
Return on Equity: 87.2%
Return on Assets: 8.66%

AbbVie Earnings Forecast

Key AbbVie Financial Ratios

  • The Gross Profit Margin over the past 13 years for ABBV is 68.96%.
  • The Selling, General & Administrative Expenses for ABBV have been equal to 21.97% of Gross Profit Margin.
  • The Research & Development expenses have been 12.61% of Revenue.
  • The Interest Expense is 20.99% of Operating Income.
  • The Net Earning history of ABBV is 20.54% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

AbbVie Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: ABBV
CUSIP: 00287Y
Website: abbvieinvestor.com

Debt

Debt-to-Equity Ratio: 4.98
Current Ratio: 0.84
Quick Ratio: 0.61

Price-to-Earnings

Trailing P/E Ratio: 22.13
Forward P/E Ratio: 11.95

ABBV Technical Analysis vs Fundamental Analysis

Buy
60
AbbVie (ABBV) is a Buy

Is AbbVie a Buy or a Sell?

  • AbbVie stock is rated a Buy
    The current AbbVie [ABBV] share price is $142.72. The Score for ABBV is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.